18F-Fluciclatide

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Asan Medical Center

Conditions

Kidney NeoplasmKidney Neoplasms

Phase 1

[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

WithdrawnNCT01633255

National Cancer Institute (NCI)Kidney Neoplasms

Start: 2012-04-18End: 2014-04-23Updated: 2019-12-17

Phase 2

[18F]Fluciclatide PET Imaging of Pazopanib Response

TerminatedNCT01961583

Asan Medical CenterKidney Neoplasm

Start: 2013-09-30End: 2016-04-30Updated: 2016-03-01